Fundraising FoxGeninus
3 known investors
Find your way into Geninus
Sign up to see every warm intro you have to Geninus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Geninus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Geninus do?
- Geninus develops IntelliMed, a platform that uses multimodal spatial transcriptomics and patient data to discover novel drug targets for oncology, particularly for modalities like TCEs and ADCs. The platform combines spatial genomics, protein profiling, and clinical outcomes to enable target discovery with reduced biological risk.
- Who founded Geninus?
- Geninus was founded by Woong Yang Park.
- Who are Geninus's investors?
- Geninus's investors include Aju IB Investment, IMM Investment Japan, Solidus Investment.